Stanford University Molecular Medicine T32 training program

A major goal of stem cell research is harnessing their remarkable potential for treating human diseases. The Stanford inter-departmental T32 predoctoral program in Molecular Medicine provides outstanding training in translational stem cell research.

Our T32 faculty have expertise in a wide variety of scientific disciplines, as well as clinical expertise in cancer therapy, gene therapy, and bone marrow transplantation. Given the importance of stem cells in tissue health and disease, a large proportion of our faculty conduct translational research and many are practicing clinicians. The Stanford T32 predoctoral program in Molecular Medicine provides outstanding training in translational research.  Our T32 students receive a customized education with a core curriculum tailored to the interface of medicine and science including a clinically-oriented journal club focusing on translational medicine led by our clinician-scientist faculty. T32 students also have the opportunity to engage with faculty in the Stanford Center for Definitive and Curative Medicine (CDCM), a joint initiative of the Stanford University School of Medicine, Stanford Health Care and Stanford Children’s Health. The CDCM is co-directed by three T32 faculty members also in the SCBRM. T32 students may elect to be co-mentored by PIs with basic and translational research programs, thereby directly bridging science and medicine during pursuit of their PhD. The Molecular Medicine PhD Program is based in the Lorry Lokey Stem Cell Research Building, where T32 students will benefit from a dynamic community of PhD students in other fields, postdoctoral fellows, and a large number of MD/PhD students.

Mission statement. 

The mission of the Stanford T32 predoctoral training program in Molecular Medicine is to rigorously train early career investigators in translational research. Unlike other PhD programs at Stanford, the Molecular Medicine program and curriculum provides education and training that specifically integrates science and medicine.

 

T32 medical journal club. 

To augment clinical education for our cohorts of T32 students in molecular medicine, we have launched a journal club series focused on translational medicine. First and second year T32 trainees will attend a medical grand rounds presentations chosen by the MD or MD/PhD clinician-scientist faculty moderator. The grand rounds seminar will be followed up with a journal club discussion of 1-2 manuscripts related to the seminar topic, led by the clinician-scientist faculty member who will provide the necessary medical background to facilitate full comprehension.

 

Program Leadership. 

The Stanford T32 Program in Molecular Medicine is co-directed by Drs. Irv Weissman, Tushar Desai, and Joanna Wysocka, three established investigators with a collective wealth of experience in research and education.

Irv Weissman, MD

Tushar Desai, MD

Joanna Wysocka, PhD

 

 

 

 

 

 

Program Eligibility. 

The NIGMS-funded Stanford T32 Program in Molecular Medicine is open to US citizens or permanent residents.

 

How to Apply.

The application process for the Molecular Medicine Training Program is integrated with the Stem Cell Biology PhD application. You may indicate your potential interest in this program during the application process, so there is no need to apply separately.